Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cocrystal Pharma, Inc.

NASDAQ: COCP · Life Sciences · 1 alert · CIK 1412486

Share price
$0.9777Close, Nov 16
Market cap
$18.8M
Shares outstanding
19.26MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cocrystal Pharma, Inc. filings on SEC EDGAR ↗

6:16 AM ET 10-Q
Financial Results

Cocrystal Pharma Q3 2026 Results: Net Loss of $3.44M, Loss Widens

Cocrystal Pharma reported a net loss of $8.9 million for the nine months ended September 30, 2026, compared to $6.4 million in the prior year, driven by increased research and development expenses. The company raised substantial doubt about its ability to continue as a going concern, noting that its $4.9 million in cash and restricted cash is insufficient to fund operations for the next 12 months.

Key figure
Net loss $3.44M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.